SS Innovations International, a pioneer in affordable surgical robotic technologies, has unveiled the world’s first Tele Surgeon Console (TSC), SSII MantrAsana — a fully integrated, ergonomic, and portable telesurgery system designed to enable remote precision operations.

Designed and manufactured entirely in India for the world, the MantrAsana TSC allows expert surgeons to extend their robotic skills beyond physical boundaries and deliver lifesaving procedures to patients anywhere in the world.

The launch event brought together experts from across the medical and surgical community, including Dr. Sudhir Srivastava, Founder and Chairman, SS Innovations International; Dr. Sudhir Rawal, Medical Director, Rajiv Gandhi Cancer Institute & Research Centre; Dr. Vishwa Srivastava, Chief Executive Officer, APAC, SS Innovations International; Dr. Lalit Malik, Chief Cardiac Surgeon, Jaipur Manipal Hospital; Dr. Somashekhar S P, Chairman, Medical Advisory Board, Aster DM Healthcare , GCC & India and Dr. Venkatesh Munikrishnan, Consultant Colorectal & Robotic Surgeon, Apollo Hospitals.

Speaking at the unveiling, Dr. Srivastava said, “With the Tele Surgeon Console, we are taking a monumental step toward making advanced surgical care accessible to everyone. Through MantrAsana TSC, we are showcasing how Indian innovation can transform healthcare delivery by bringing the surgeon’s expertise directly to the patient regardless of geography.”

He noted that the compact design allows surgeons to perform telesurgeries remotely from their offices, without tying up operating theatres.

“There is a huge advantage because of the console’s smaller footprint, being a self-contained chair wherein all electronics are inbuilt into the chair. The surgeon wears very light weight glasses with a magnified 3D view and uses magnetic sensor-based controls to control the movements of the robotic system remotely. This should be looked at as an advancement whereby these smaller telesurgery units can be placed anywhere to extend the expertise,” he added.

Dr. Rawal highlighted that the technology will make best surgeons and the highest standards of care will be available in remote areas.

“MantrAsana TSC represents a new era in surgical innovation, combining advanced robotics, precision controls and immersive 3D visualization to make remote surgery a reality,” he said.

MantrAsana TSC is expected to be commercially available by December 2025 in India and followed by global footprints.

An American company headquartered in India, SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary “SSII Mantra” surgical robotic system and its comprehensive suite of “SSII Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery.